Home › Trial NCT05053555
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
- Trial IDNCT05053555
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment60
- Start date2022-04-24
- ConditionsLiver Malignant Tumors · Cholangiocarcinoma Metastatic · Pancreatic Cancer · Melanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.